Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,686,936.21
- $27,078,730.06
- Aug. 8, 2025
- Todd Franklin Watanabe
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 27, 2021 | CFO | 12,560 | $20.07 | Sell | $252,079.20 | |
| Dec. 23, 2021 | Director | 2,500 | $20.16 | Sell | $50,400.00 | |
| Dec. 8, 2021 | CEO | 1,000 | $17.00 | Sell | $17,000.00 | |
| Nov. 5, 2021 | CEO | 1,000 | $21.50 | Sell | $21,500.00 | |
| Nov. 1, 2021 | Director | 2,500 | $21.81 | Sell | $54,525.00 | |
| Oct. 5, 2021 | CEO | 2,500 | $24.92 | Sell | $62,300.00 | |
| Sept. 7, 2021 | CEO | 1,000 | $21.14 | Sell | $21,140.00 | |
| Aug. 5, 2021 | CEO | 1,000 | $20.81 | Sell | $20,810.00 | |
| July 6, 2021 | CEO | 1,750 | $26.58 | Sell | $46,515.00 | |
| July 1, 2021 | Director | 2,200 | $26.13 | Sell | $57,486.00 | |
| June 24, 2021 | Director | 729 | $27.50 | Sell | $20,047.50 | |
| June 21, 2021 | Director | 2,516 | $27.50 | Sell | $69,190.00 | |
| June 7, 2021 | CEO | 1,750 | $26.35 | Sell | $46,112.50 | |
| May 7, 2021 | CEO | 750 | $35.00 | Sell | $26,250.00 | |
| May 5, 2021 | CEO | 1,750 | $34.00 | Sell | $59,500.00 | |
| April 20, 2021 | Director | 10,000 | $28.06 | Sell | $280,600.00 | |
| April 5, 2021 | CEO | 1,750 | $29.93 | Sell | $52,377.50 | |
| April 1, 2021 | Director | 2,200 | $29.49 | Sell | $64,878.00 | |
| March 22, 2021 | Director | 10,000 | $31.10 | Sell | $311,000.00 | |
| March 5, 2021 | CEO | 1,750 | $30.55 | Sell | $53,462.50 | |
| Feb. 10, 2021 | CFO | 750 | $35.64 | Sell | $26,730.00 | |
| Feb. 1, 2021 | Director | 9,949 | $33.25 | Sell | $330,804.25 | |
| Feb. 1, 2021 | CFO | 1,250 | $35.00 | Sell | $43,750.00 | |
| Jan. 29, 2021 | Director | 51 | $27.50 | Sell | $1,402.50 | |
| Jan. 19, 2021 | CFO | 500 | $30.00 | Sell | $15,000.00 | |
| Dec. 1, 2020 | Director | 2,200 | $25.98 | Sell | $57,156.00 | |
| Oct. 1, 2020 | Director | 2,200 | $27.65 | Sell | $60,830.00 | |
| Sept. 29, 2020 | Insider | 15,000 | $30.00 | Sell | $450,000.00 | |
| Sept. 29, 2020 | CFO | 500 | $30.00 | Sell | $15,000.00 | |
| Sept. 29, 2020 | CEO | 3,000 | $30.00 | Sell | $90,000.00 | |
| Sept. 1, 2020 | Director | 2,200 | $24.38 | Sell | $53,636.00 | |
| Aug. 3, 2020 | Director | 2,800 | $25.63 | Sell | $71,764.00 | |
| Feb. 4, 2020 | Major Shareholder | 500,000 | $24.10 | Buy | $12,050,000.00 | |
| Feb. 3, 2020 | Director | 558,888 | $25.64 | Buy | $14,329,888.32 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Scott L Burrows, John W. Smither, Larry Todd Edwards, Patricia A Turney, Patrick J Heron, Orbimed Advisors Llc, Life Sciences Viii L Frazier, OSBORNE DAVID W, Watanabe Todd Franklin, David W Osborne, Howard G. Welgus, Welgus Howard G., Terrie Curran, David Joseph Topper, Jonathan Silverstein, Todd Watanabe, Latha Vairavan, and David W. Osborne
The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 31 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on Aug. 8, 2025.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.